ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

292
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
bullishCelltrion Inc
06 Mar 2018 19:53

Celltrion & Celltrion Healthcare Placement - Spread Should Narrow as Inclusion Draws Closer

Ion Investment (Temasek) is looking to sell its stake in 2.24m and 2.9m shares in Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS)...

Share
bullishToshiba Corp
26 Feb 2018 00:28

The Two Weeks in NorthAsia@Smartkarma That Were: BOJ/N225, Buybacks, & Biosimilars

The past two weeks involved a long Chinese New Year holiday for many so last weekend's Week That Was was carried over. The "slow" two week period...

Logo
178 Views
Share
bearishCelltrion Inc
15 Feb 2018 23:24

Biosimilar Battlefield: An Update

Korea's biosimilar plays, Celltrion Inc (068270 KS) , Celltrion Pharm Inc (068760 KS) , Celltrion Healthcare (091990 KS) , and Samsung Biologics...

Share
bearishSamsung C&T
24 Dec 2017 21:58

Samsung Governance Reform - Why Local Institutions Turning Away from C&T?

It certainly seems that this is a very rare event. Honestly, I don't recall anything like this, that one of Korea's top regulation agencies...

Logo
171 Views
Share
28 Nov 2017 16:52

Drugs Evolving Into 'Biological Software' to Boost Moribund Pharma Sector?

The global pharma and biotech sector has underperformed by about four points this year, and five over three years – the divergence with other...

Logo
219 Views
Share
x